Sort
30,917 grants matching “tumor microenvironment”
Regulatory T cells in cancer therapy
$634,434Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$634,432William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
$634,364Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
$634,298Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Regulatory T cells in cancer therapy
$634,296Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment
$634,276James S Duncan · Yale University · R01 · FY2018 · CA
Gamma delta T cell based melanoma therapies
$634,246Xiaowei Xu · University Of Pennsylvania · R01 · FY2025 · CA
Optimizing TCR-CD3 signaling for immunotherapy of cancer
$634,208Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2025 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort
$634,182Laura Rozek · Georgetown University · R01 · FY2025 · CA
Tumor-associated pDC (TApDC) in liver cancer with HIV infection
$634,061Lishan Su · University Of Maryland Baltimore · R01 · FY2025 · CA
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy
$633,891Melissa J Suter · Massachusetts General Hospital · R01 · FY2022 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$633,869Duane A. Mitchell · University Of Florida · R01 · FY2017 · CA
Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance
$633,787Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Image-based models of tumor-immune dynamics in glioblastoma
$633,782Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2024 · CA
Administrative Core
$633,675Haifa Shen · Methodist Hospital Research Institute · U54 · FY2019 · CA
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
$633,662Taha Merghoub · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Improving IL12 Immunogene Therapy for Glioblastoma Based on Human Clinical Trial Results
$633,656E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2024 · NS
Improving IL12 Immunogene Therapy for Glioblastoma Based on Human Clinical Trial Results
$633,656E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2025 · NS
Novel CAR T cell engineering strategies for effective eradication of solid and liquid tumors
$633,633Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2025 · CA
Multiscale systems biology modeling to exploit tumor-stromal metabolic crosstalk in colorectal cancer
$633,538Stacey Deleria Finley · University Of Southern California · U01 · FY2018 · CA
Inflammation And Submucosal Glands During Esophageal Injury And Repair
$633,534Katherine Garman · Case Western Reserve University · P01 · FY2025 · CA
Metabolic impact on T cell-mediated cancer immunity and therapy
$633,500Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Metabolic impact on T cell-mediated cancer immunity and therapy
$633,444Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Sustaining antitumor effector CD8+ T cells for cancer therapy
$633,355Bin Zhang · Northwestern University At Chicago · R01 · FY2024 · CA
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
$633,309Balabhaskar Prabhakarpandian · Cfd Research Corporation · R44 · FY2012 · CA